Nano Materials Science2025，Vol.7Issue(5)：P.627-642,16.DOI:10.1016/j.nanoms.2024.06.004
Advanced Ca-doped MOF nanocarriers for Co-delivery of Doxorubicin/pCRISPR
Bahareh Farasati Far 1Mohammad Reza Naimi-Jamal 1Sepideh Ahmadi 2Navid Rabiee3
作者信息
- 1. Research Laboratory of Green Organic Synthesis and Polymers,Department of Chemistry,Iran University of Science and Technology,Tehran,1684611367,Iran
- 2. Student Research Committee,Department of Medical Biotechnology,School of Advanced Technologies in Medicine,Shahid Beheshti University of Medical Sciences,Tehran,Iran Cellular and Molecular Biology Research Center,Shahid Beheshti University of Medical Sciences,Tehran,Iran
- 3. School of Chemistry,Damghan University,36716-45667,Damghan,Iran Department of Biomaterials,Saveetha Dental College and Hospitals,SIMATS,Saveetha University,Chennai 600077,India
- 折叠
摘要
关键词
Synergistic therapy/Nanoparticle drug delivery/Gene editing/Metal-organic framework/Combinational therapy/Cancer nanotechnology分类
医药卫生引用本文复制引用
Bahareh Farasati Far,Mohammad Reza Naimi-Jamal,Sepideh Ahmadi,Navid Rabiee..Advanced Ca-doped MOF nanocarriers for Co-delivery of Doxorubicin/pCRISPR[J].Nano Materials Science,2025,7(5):P.627-642,16.
